AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30

Authors: GOBERT A RIVET JM AUDINOT V NEWMANTANCREDI A CISTARELLI L MILLAN MJ
Citation: A. Gobert et al., SIMULTANEOUS QUANTIFICATION OF SEROTONIN, DOPAMINE AND NORADRENALINE LEVELS IN SINGLE FRONTAL-CORTEX DIALYSATES OF FREELY-MOVING RATS REVEALS A COMPLEX PATTERN OF RECIPROCAL AUTO-MEDIATED AND HETERORECEPTOR-MEDIATED CONTROL OF RELEASE, Neuroscience, 84(2), 1998, pp. 413-429

Authors: MILLAN MJ DEKEYNE A GOBERT A
Citation: Mj. Millan et al., SEROTONIN (5-HT)(2C) RECEPTORS TONICALLY INHIBIT DOPAMINE (DA) AND NORADRENALINE (NA), BUT NOT 5-HT, RELEASE IN THE FRONTAL-CORTEX IN-VIVO, Neuropharmacology, 37(7), 1998, pp. 953-955

Authors: MILLAN MJ NEWMANTANCREDI A BROCCO N GOBERT A LEJEUNE F AUDINOT V RIVET JM SCHREIBER R DEKEYNE A SPEDDING M NICOLAS JP PEGLION JL
Citation: Mj. Millan et al., S-18126 4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)PIPERAZIN-1-YL METHYL]INDAN-2-YL)), A POTENT, SELECTIVE AND COMPETITIVE ANTAGONIST AT DOPAMINE D-4 RECEPTORS - AN IN-VITRO AND IN-VIVO COMPARISON WITH L-745,870 YL]PIPERAZIN-1-YL)METHYL-1H-PYRROLO[2,3B]PYRIDINE) AND RACLOPRIDE, The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 167-186

Authors: AUDINOT V NEWMANTANCREDI A GOBERT A RIVET JM BROCCO M LEJEUNE F GLUCK L DESPOSTE I BERVOETS K DEKEYNE A MILLAN MJ
Citation: V. Audinot et al., A COMPARATIVE IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL DOPAMINE D-3 RECEPTOR ANTAGONISTS (-S-14297, NAFADOTRIDE, GR-103,691 AND U-99194()), The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 187-197

Authors: MILLAN MJ GOBERT A NEWMANTANCREDI A AUDINOT V LEJEUNE F RIVET JM CUSSAC D NICOLAS JP MULLER O LAVIELLE G
Citation: Mj. Millan et al., S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - I - RECEPTORIAL AND NEUROCHEMICAL PROFILE COMPARISON WITH CLOZAPINE AND HALOPERIDOL, The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1341-1355

Authors: MILLAN MJ BROCCO M VEIGA S CISTARELLI L MELON C GOBERT A
Citation: Mj. Millan et al., WAY-100,635 ENHANCES BOTH THE ANTIDEPRESSANT ACTIONS OF DULOXETINE AND ITS INFLUENCE ON DIALYSATE LEVELS OF SEROTONIN IN FRONTAL-CORTEX, European journal of pharmacology, 341(2-3), 1998, pp. 165-167

Authors: MILLAN MJ NEWMANTANCREDI A RIVET JM BROCCO M LACROIX P AUDINOT V CISTARELLI L GOBERT A
Citation: Mj. Millan et al., S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .1. INTERACTION WITH CLONED HUMAN (H)5-HT1A, DOPAMINE HD(2) HD(3) AND H-ALPHA(2A)-ADRENERGIC RECEPTORS IN RELATION TO MODULATION OF CORTICAL MONOAMINE RELEASE AND ACTIVITY IN MODELS OF POTENTIAL ANTIDEPRESSANT ACTIVITY/, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 132-147

Authors: GOBERT A RIVET JM CISTARELLI L MELON C MILLAN MJ
Citation: A. Gobert et al., ALPHA(2)-ADRENERGIC RECEPTOR BLOCKADE MARKEDLY POTENTIATES DULOXETINE-INDUCED AND FLUOXETINE-INDUCED INCREASES IN NORADRENALINE, DOPAMINE, AND SEROTONIN LEVELS IN THE FRONTAL-CORTEX OF FREELY MOVING RATS, Journal of neurochemistry, 69(6), 1997, pp. 2616-2619

Authors: GOBERT A RIVET JM CISTARELLI L MILLAN MJ
Citation: A. Gobert et al., POTENTIATION OF THE FLUOXETINE-INDUCED INCREASE IN DIALYSATE LEVELS OF SEROTONIN (5-HT) IN THE FRONTAL-CORTEX OF FREELY MOVING RATS BY COMBINED BLOCKADE OF 5-HT1A AND 5-HT1B RECEPTORS WITH WAY-100,635 AND GR-127,935, Journal of neurochemistry, 68(3), 1997, pp. 1159-1163

Authors: GOBERT A RIVET JM CISTARELLI L MILLAN MJ
Citation: A. Gobert et al., BUSPIRONE ENHANCES DULOXETINE-INDUCED AND FLUOXETINE-INDUCED INCREASES IN DIALYSATE LEVELS OF DOPAMINE AND NORADRENALINE, BUT NOT SEROTONIN, IN THE FRONTAL-CORTEX OF FREELY MOVING RATS, Journal of neurochemistry, 68(3), 1997, pp. 1326-1329

Authors: NEWMANTANCREDI A AUDINOTBOUCHEZ V GOBERT A MILLAN MJ
Citation: A. Newmantancredi et al., NORADRENALINE AND ADRENALINE ARE HIGH-AFFINITY AGONISTS AT DOPAMINE D-4 RECEPTORS, European journal of pharmacology, 319(2-3), 1997, pp. 379-383

Authors: MILLAN MJ GOBERT A
Citation: Mj. Millan et A. Gobert, AUTORECEPTOR AND HETEROCEPTOR CONTROL OF 5-HT, DOPAMINE (DA) AND NORADRENALINE (NAD) RELEASE IN FRONTAL-CORTEX - STRATEGIES FOR IMPROVED ANTIDEPRESSANT AGENTS, British Journal of Pharmacology, 122, 1997, pp. 468-468

Authors: HUBER A SANDER P GOBERT A BAHNER M HERMANN R PAULSEN R
Citation: A. Huber et al., THE TRANSIENT RECEPTOR POTENTIAL PROTEIN (TRP), A PUTATIVE STORE-OPERATED CA2-MEDIATED PHOTORECEPTION, FORMS A SIGNALING COMPLEX WITH NORPA, INAC AND INAD( CHANNEL ESSENTIAL FOR PHOSPHOINOSITIDE), EMBO journal, 15(24), 1996, pp. 7036-7045

Authors: GOBERT A LEJEUNE F RIVET JM CISTARELLI L MILLAN MJ
Citation: A. Gobert et al., DOPAMINE D-3 (AUTO) RECEPTORS INHIBIT DOPAMINE RELEASE IN THE FRONTAL-CORTEX OF FREELY MOVING RATS IN-VIVO, Journal of neurochemistry, 66(5), 1996, pp. 2209-2212

Authors: MILLAN MJ PEGLION JL VIAN J RIVET JM BROCCO M GOBERT A NEWMANTANCREDI A DACQUET C BERVOETS K GIRARDON S JACQUES V CHAPUT C AUDINOT V
Citation: Mj. Millan et al., FUNCTIONAL CORRELATES OF DOPAMINE D-3 RECEPTOR ACTIVATION IN THE RAT IN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .1. ACTIVATION OF POSTSYNAPTIC D-3, RECEPTORS MEDIATES HYPOTHERMIA, WHEREAS BLOCKADE OF D-2 RECEPTORS ELICITS PROLACTIN SECRETION AND CATALEPSY()), The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 885-898

Authors: GOBERT A RIVET JM AUDINOT V CISTARELLI L SPEDDING M VIAN J PEGLION JL MILLAN MJ
Citation: A. Gobert et al., FUNCTIONAL CORRELATES OF DOPAMINE D-3, RECEPTOR ACTIVATION IN THE RATIN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .2. BOTH D-2 AND SILENT D-3 AUTORECEPTORS CONTROL SYNTHESIS AND RELEASEIN MESOLIMBIC, MESOCORTICAL AND NIGROSTRIATAL PATHWAYS()), The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 899-913

Authors: GOBERT A LEJEUNE F RIVET JM AUDINOT V NEWMANTANCREDI A MILLAN MJ
Citation: A. Gobert et al., MODULATION OF THE ACTIVITY OF CENTRAL SEROTONINERGIC NEURONS BY NOVELSEROTONIN(1A) RECEPTOR AGONISTS AND ANTAGONISTS - A COMPARISON TO ADRENERGIC AND DOPAMINERGIC-NEURONS IN RATS, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1032-1046

Authors: MILLAN MJ RIVET JM AUDINOT V GOBERT A LEJEUNE F BROCCO M NEWMANTANCREDI A MAURELREMY S BERVOETS K
Citation: Mj. Millan et al., ANTAGONIST PROPERTIES OF LY-165,163 AT PRESYNAPTIC AND POSTSYNAPTIC DOPAMINE D-2, D-3, AND D-1 RECEPTORS - MODULATION OF AGONIST ACTIONS AT5-HT1A RECEPTORS IN-VIVO, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1418-1427

Authors: SCHREIBER R BROCCO M AUDINOT V GOBERT A VEIGA S MILLAN MJ
Citation: R. Schreiber et al., (1-(2,5-DIMETHOXY-4 IODOPHENYL)-2-AMINOPROPANE)-INDUCED HEAD-TWITCHESIN THE RAT ARE MEDIATED BY 5-HYDROXYTRYPTAMINE (5-HT)(2A) RECEPTORS -MODULATION BY NOVEL 5-HT2A 2C ANTAGONISTS, D-1 ANTAGONISTS AND 5-HT1AAGONISTS/, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 101-112

Authors: PEGLION JL CANTON H BERVOETS K AUDINOT V BROCCO M GOBERT A LEMAROUILLEGIRARDON S MILLAN MJ
Citation: Jl. Peglion et al., CHARACTERIZATION OF POTENT AND SELECTIVE ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS IN A SERIES OF N4-SUBSTITUTED ARYLPIPERAZINES, Journal of medicinal chemistry, 38(20), 1995, pp. 4044-4055

Authors: MILLAN MJ BERVOETS K RIVET JM WIDDOWSON P RENOUARD A LEMAROUILLEGIRARDON S GOBERT A
Citation: Mj. Millan et al., MULTIPLE ALPHA-2-ADRENERGIC RECEPTOR SUBTYPES .2. EVIDENCE FOR A ROLEOF RAT R(ALPHA-2A), ADRENERGIC-RECEPTORS IN THE CONTROL OF NOCICEPTION, MOTOR BEHAVIOR AND HIPPOCAMPAL SYNTHESIS OF NORADRENALINE, The Journal of pharmacology and experimental therapeutics, 270(3), 1994, pp. 958-972

Authors: MILLAN MJ RIVET JM GOBERT A CANTON H VEIGA S BERVOETS K
Citation: Mj. Millan et al., 5-HT1A RECEPTORS AND THE TAIL-FLICK RESPONSE .6. INTRINSIC ALPHA(1A)-ADRENOCEPTOR ANTAGONIST PROPERTIES CAN MASK THE ACTIONS OF 5-HT1A RECEPTOR AGONISTS IN THE SPONTANEOUS TAIL-FLICK PARADIGM, The Journal of pharmacology and experimental therapeutics, 269(1), 1994, pp. 121-131

Authors: MILLAN MJ CANTON H GOBERT A LEJEUNE F RIVET JM BERVOETS K BROCCO M WIDDOWSON P MENNINI T AUDINOT V HONORE P RENOUARD A LEMAROUILLEGIRARDON S VERRIELE L GRESSIER H PEGLION JL
Citation: Mj. Millan et al., NOVEL BENZODIOXOPIPERAZINES ACTING AS ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS AND AS AGONISTS AT 5-HT1A AUTORECEPTORS - A COMPARATIVE PHARMACOLOGICAL CHARACTERIZATION WITH PROPOSED 5-HT1A ANTAGONISTS, The Journal of pharmacology and experimental therapeutics, 268(1), 1994, pp. 337-352

Authors: SCHREIBER R BROCCO M GOBERT A VEIGA S MILLAN MJ
Citation: R. Schreiber et al., THE POTENT ACTIVITY OF THE 5-HT1A RECEPTOR AGONISTS, S-14506 AND S-14671, IN THE RAT FORCED SWIM TEST IS BLOCKED BY NOVEL 5-HT1A-RECEPTOR ANTAGONISTS, European journal of pharmacology, 271(2-3), 1994, pp. 537-541

Authors: RIVET JM AUDINOT V GOBERT A PEGLION JL MILLAN MJ
Citation: Jm. Rivet et al., MODULATION OF MESOLIMBIC DOPAMINE RELEASE BY THE SELECTIVE DOPAMINE-D-3 RECEPTOR ANTAGONIST, (-S-14297()), European journal of pharmacology, 265(3), 1994, pp. 175-177
Risultati: 1-25 | 26-30